Pexacerfont is a selective androgen receptor modulator developed to address muscle wasting associated with cancer cachexia by targeting androgen receptors in skeletal muscle tissue. This category provides… Read more
Pexacerfont is a selective androgen receptor modulator developed to address muscle wasting associated with cancer cachexia by targeting androgen receptors in skeletal muscle tissue. This category provides essential reference standards for the systematic investigation and analytical control of the drug substance. Included in this collection are high-purity forms of Pexacerfont, which serve as foundational materials for potency testing and impurity profiling. Pharmaceutical laboratories utilize the stable isotope-labelled Pexacerfont-13C-d3 as an internal standard for precise quantitative analysis via mass spectrometry, ensuring accurate results during method validation. Furthermore, the inclusion of N-Nitroso Pexacerfont allows for the detection and quantification of potential nitrosamine impurities, supporting rigorous quality control protocols and regulatory compliance throughout the manufacturing process. These specialized compounds are critical for researchers and analytical chemists maintaining stringent safety and efficacy standards in pharmaceutical development.